Americans get back to their spending ways. Economy might be speeding up again.

A tough job market is pushing more young Americans to make a big bet: on themselves

The 15 worst-performing S&P 500 stocks during a dismal September

Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

This is the big risk that stock investors should be watching as rising bond yields menace markets

‘I’m afraid of human stupidity’: Why this top economist prefers U.S. tech and gold over bonds